Opendata, web and dolomites

REBOOT SIGNED

First-in-class implants for bone regeneration surgery after a bone, ligament or tendon injury

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 REBOOT project word cloud

Explore the words cloud of the REBOOT project. It provides you a very rough idea of what is the project "REBOOT" about.

ceramic    operation    rate    full    cruciate    injury    msd    surgery    billions    noraker    toward    create    feasibility    weights    shows    structure    enter    sme    multiplied    15    abnormal    healing    bioresorbable    spiral    life    ages    class    experiencing    fragile    mixed    glass    metallic    people    first    develops    adoption       days    re    population    millions    market    screw    community    capablity    regeneration    trauma    transition    ligament    synthetic    implants    bioabsorbable    turnover    pain    regenerative    2015    bone    ligaments    disorders    world    poor    20    tendon    perspectives    surgical    2018    revolutionary    follow    100    manufacturing    industrial    sales    leaving    suffering    chronic    biocomposite    action    outcomes    imperfect    revision    materials    patients    bioactive    worldwide    bones    polymer    patented    functional    native    disruptive    instrument    quality    recreate    orthopaedic    international    made    knee    million    formula    30    marketed    launch    injuries    too    break    musculoskeletal    reboot    validated    inflammation    msds   

Project "REBOOT" data sheet

The following table provides information about the project.

Coordinator
NORAKER 

Organization address
address: 11/13 AVENUE ALBERT EINSTEIN CENTRE SCIENTIFIQUE ET TECHNOLOGIQUE
city: VILLEURBANNE
postcode: 69100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 3˙545˙000 €
 EC max contribution 2˙481˙500 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2021-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NORAKER FR (VILLEURBANNE) coordinator 2˙481˙500.00

Map

 Project objective

NORAKER develops first-in-class implants for regenerative orthopaedic surgery to offer full healing to patients suffering from a bone, ligament or tendon injury. With project REBOOT, NORAKER will create the market of bone regeneration surgery. Each year in Europe, 1,6 million people require orthopaedic surgery after a bone, ligament or tendon injury, with many more cases expected as population ages. The current implants (made of metallic or bioresorbable materials) show imperfect healing outcomes, leaving millions of patients with fragile bones and poor quality of life (with 30% of inflammation, 20% of revision surgery and millions suffering from chronic pain and musculoskeletal disorders, MSDs). It weights billions of follow-up costs on the community. Enter NORAKER’s biocomposite surgical implants, made of bioactive glass – a revolutionary ceramic – mixed with a synthetic polymer, both bioabsorbable. This technology shows disruptive regeneration action: it can recreate up to 100% of the native-like functional bone structure with no inflammation, no abnormal pain, no MSD and a very low re-operation rate (4%). Today this patented technology is adapted to knee cruciate ligaments regeneration (with a world-first biocomposite screw marketed in 2015). In a SME Instrument Phase 1 project (2018), NORAKER has validated the feasibility of a new biocomposite formula with broader perspectives of regeneration for tendon, ligament and bone injuries. The Phase 2 project will do the industrial scale-up of this biocomposite and launch the industrial production of the first range of implants for the bone trauma market. Their adoption will support the transition toward regenerative orthopaedic surgery and break the spiral of pain and MSDs, which too many patients are experiencing these days. With this disruptive offer, NORAKER will become a scale-up operating worldwide, with a large manufacturing capablity, international sales and turnover multiplied by 15 in five years.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REBOOT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REBOOT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

Skye (2018)

Redefining Drone Safety and Autonomous Operation for Indoor Commercial Applications

Read More